Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05BMP
|
|||
| Former ID |
DNC005205
|
|||
| Drug Name |
5''-Quinolin-4-yl-[2,4'']bithiazolyl-2''-ylamine
|
|||
| Synonyms |
CHEMBL362710; BDBM50151351; 5''-(quinolin-4-yl)-2,4''-bithiazol-2''-amine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H10N4S2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)C(=CC=N2)C3=C(N=C(S3)N)C4=NC=CS4
|
|||
| InChI |
1S/C15H10N4S2/c16-15-19-12(14-18-7-8-20-14)13(21-15)10-5-6-17-11-4-2-1-3-9(10)11/h1-8H,(H2,16,19)
|
|||
| InChIKey |
JHZIIPPDVRVCNU-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors. J Med Chem. 2004 Aug 26;47(18):4494-506. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.